S. 5002 · 117th Congress
FDA Modernization Act 2.0
- Stage
- Passed a chamber
- Sponsor
- Rand Paul
- Introduced
- 2022-09-29
- Latest action
- 2022-09-29 · Held at the desk.
Summary
FDA Modernization Act 2.0
This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.
The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.